Health Canada on Monday approved Pfizer’s drug, Paxlovid, as the first take-home treatment for COVID-19, The National Post reported.
The public health agency recommended that immunocompromised people be the top priority for the medication, followed by unvaccinated or partially vaccinated people over 80 years old, people in their 60s and people in rural and remote communities where access to hospital care could be difficult.
Read more